Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Aydin, Sibel; Robson, Joanna; Sreih, Antoine; Hill, Catherine; Alibaz-Oner, FATMA; Mackie, Sarah; Beard, Susan; Gül, Ahmet; Hatemi, Gulen; Kermani, Tanaz; Mahr, Alfred; Meara, Alexa; Milman, Nataliya; Shea, Beverley; Tomasson, Gunnar; Tugwell, Peter; Direskeneli, RAFİ; Merkel, Peter

doi:10.3899/jrheum.181072

Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018

Aydin S. Z., Robson J. C., Sreih A. G., Hill C., Alibaz-Oner F., Mackie S., ...Daha Fazla

JOURNAL OF RHEUMATOLOGY, cilt.46, sa.9, ss.1198-1201, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 46 Sayı: 9
Basım Tarihi: 2019
Doi Numarası: 10.3899/jrheum.181072
Dergi Adı: JOURNAL OF RHEUMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1198-1201
Anahtar Kelimeler: VASCULITIS, TAKAYASU ARTERITIS, GIANT CELL ARTERITIS, LARGE-VESSEL VASCULITIS, OUTCOMES, OMERACT, QUALITY-OF-LIFE, GIANT-CELL ARTERITIS, DISEASE-ACTIVITY, TAKAYASUS-ARTERITIS, ACTIVITY SCORE, HEALTH
Marmara Üniversitesi Adresli: Evet

Özet

Objective. The Outcome Measures in Rheumatology (OMERACT) Vasculitis Working Group seeks to develop validated outcome measures for use in trials for large-vessel vasculitis (LVV).